Today, Naprod enjoys a global reach with significant reach across India as well as serve countries in the continents of Asia, Europe, Latin America and Africa. Naprod has developed scores of dossiers approved by regulators from different countries available for out-licensing in emerging markets.
Naprod’s emerging market presence spreads across South-East Asia, Africa, Russia, CIS and Latin American countries. We are currently looking to expand our base by offering our Oncology and General formulations portfolio to a partner having a complimentary portfolio
Read MoreNaprod is one of the pioneers in manufacturing of Lyophilized Injections and OSD Oncology products. With our extensive expertise and capabilities, we offer competitive, high quality, custom end-to-end manufacturing services from API manufacturing through our group company Macchem. Including formulation development, analytical method development and validation, small scale & commercial scale production. The manufacturing facilities have been accredited by various international regulators including the ANVISA Brazil, INVIMA Colombia, PICS and other major approvals from Africa and CIS.
Read MoreNaprod has invested in expanding the entire spectrum of services to support projects from formulation to finished products. Labs are equipped for formulation and analytical development, including stability studies, method development and validation. Naprod believes in quick and timely delivery with QCD (Quality, Cost and Delivery) approach as per needs.
Read More